The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
12 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $10,101,176 in first-year total cost, median $851,478.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-E (J1)]12
Most frequent institutions
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- DANA-FARBER CANCER INST1
- DUKE UNIVERSITY1
- JOHNS HOPKINS UNIVERSITY1
- MAYO CLINIC ROCHESTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | ViKTriY Early Clinical Trials Consortium (ECTC)1UM1CA186689-01 | LORUSSO, PATRICIA M. | YALE UNIVERSITY, CT | $1,420,000 | ZCA1 |
| 2014 | Dana-Farber/Harvard Cancer Center ET-CTN with Phase I Emphasis1UM1CA186709-01 | FLAHERTY, KEITH TKUFE, DONALD W.SHAPIRO, GEOFFREY I | DANA-FARBER CANCER INST, MA | $1,400,003 | ZCA1 |
| 2014 | Southwest Early Clinical Trials Consortium1UM1CA186688-01 | ECKHARDT, S. GAILMERIC-BERNSTAM, FUNDAYAO, JAMES C | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $949,998 | ZCA1 |
| 2014 | Phase I Molecular and Clinical Pharmacodynamic Trials ET-CTN1UM1CA186717-01 | LENZ, HEINZ JOSEFNEWMAN, EDWARD M | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $900,656 | ZCA1 |
| 2014 | The Johns Hopkins Translational Science Team for the ET-CTN1UM1CA186691-01 | CARDUCCI, MICHAEL AGOCKE, CHRISTOPHER DGOJO, IVANARUDEK, MICHELLE A | JOHNS HOPKINS UNIVERSITY, MD | $899,999 | ZCA1 |
| 2014 | Experimental Therapeutics of Anti-Cancer Agents with Phase I Emphasis1UM1CA186712-01 | GREVER, MICHAEL R | OHIO STATE UNIVERSITY, OH | $852,262 | ZCA1 |
| 2014 | NCI ET-CTN with Phase i Emphasis at UPCI1UM1CA186690-01 | CHU, EDWARD | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $850,694 | ZCA1 |
| 2014 | Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics1UM1CA186716-01 | DIPAOLA, ROBERT S.LIU, GLENN | RBHS -CANCER INSTITUTE OF NEW JERSEY, NJ | $849,999 | ZCA1 |
| 2014 | NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis1UM1CA186686-01 | ERLICHMAN, CHARLESHALUSKA, PAUL | MAYO CLINIC ROCHESTER, MN | $559,998 | ZCA1 |
| 2014 | Experimental Therapeutics: Clinical Trials Network with Phase I Emphasis1UM1CA186705-01 | MAITLAND, MICHAEL L.RATAIN, MARK J | UNIVERSITY OF CHICAGO, IL | $510,000 | ZCA1 |
| 2014 | Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer1UM1CA186704-01 | DEES, ELIZABETH CLAIREHURWITZ, HERBERT ILOCKHART, ALBERT CRAIG | DUKE UNIVERSITY, NC | $506,170 | ZCA1 |
| 2014 | Princess Margaret Phase I Consorium (PMP1C)1UM1CA186644-01 | SIU, LILLIAN L | UNIVERSITY HEALTH NETWORK, ON | $401,397 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.